Recent advances in treatment for Benign Prostatic Hyperplasia
- PMID: 26918132
- PMCID: PMC4754003
- DOI: 10.12688/f1000research.7063.1
Recent advances in treatment for Benign Prostatic Hyperplasia
Abstract
Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbidity. The future of BPH treatments is exciting, and a number of novel techniques are currently under clinical trial.
Keywords: HOLEP; Holmium laser enucleation of the prostate; aquablation; benign prostatic hyperplasia; mirabegron; personalised medicine; prostate obstruction.
Conflict of interest statement
No competing interests were disclosed.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources